Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders after COVID-19: A Nationwide Population-based Study of Korea

Supplemental Table 1. International Statistical Classification of Diseases, tenth revision (ICD-10) codes of the included diseases Supplemental Table 2. Demographic and health characteristics of COVID-19 and contemporary controls before and after weighting Supplemental Table 3. Demographic and health characteristics of COVID-19 and historical controls before and after weighting Supplemental Figure 1. Covariate balance after application of inverse probability weighting Supplemental Figure 2. Positive and negative outcomes Supplemental Figure 3. Sensitivity analyses: risk of incident autoimmune and autoinflammatory disease outcomes in COVID-19 cohort compared with the contemporary control cohort. Supplemental Figure 4. Sensitivity analyses: risk of incident autoimmune and autoinflammatory disease outcomes in COVID-19 cohort compared with the historical control cohort. Supplemental Figure 5. Sensitivity analyses: subgroup analyses of the risk of incident autoimmune and autoinflammatory disease outcomes in COVID-19 cohort compared with the contemporary control cohort. Supplemental Figure 6. Sensitivity analyses: subgroup analyses of the risk of incident autoimmune and autoinflammatory disease outcomes in COVID-19 cohort compared with the historical control cohort.